- Home
- AMBC vs ABUS Comparison
AMBC vs ABUS Comparison
Compare AMBC & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- ABUS
- Stock Information
- Founded
- AMBC 1991
- ABUS N/A
- Country
- AMBC United States
- ABUS United States
- Employees
- AMBC N/A
- ABUS N/A
- Industry
- AMBC Property-Casualty Insurers
- ABUS Biotechnology: Pharmaceutical Preparations
- Sector
- AMBC Finance
- ABUS Health Care
- Exchange
- AMBC Nasdaq
- ABUS Nasdaq
- Market Cap
- AMBC 544.2M
- ABUS 629.1M
- IPO Year
- AMBC 1991
- ABUS N/A
- Fundamental
- Price
- AMBC $11.59
- ABUS $3.42
- Analyst Decision
- AMBC Strong Buy
- ABUS Strong Buy
- Analyst Count
- AMBC 2
- ABUS 4
- Target Price
- AMBC $17.00
- ABUS $5.50
- AVG Volume (30 Days)
- AMBC 379.9K
- ABUS 646.4K
- Earning Date
- AMBC 02-26-2025
- ABUS 03-03-2025
- Dividend Yield
- AMBC N/A
- ABUS N/A
- EPS Growth
- AMBC N/A
- ABUS N/A
- EPS
- AMBC N/A
- ABUS N/A
- Revenue
- AMBC $398,000,000.00
- ABUS $6,742,000.00
- Revenue This Year
- AMBC N/A
- ABUS N/A
- Revenue Next Year
- AMBC N/A
- ABUS N/A
- P/E Ratio
- AMBC N/A
- ABUS N/A
- Revenue Growth
- AMBC 22.46
- ABUS N/A
- 52 Week Low
- AMBC $10.12
- ABUS $2.30
- 52 Week High
- AMBC $18.45
- ABUS $4.72
- Technical
- Relative Strength Index (RSI)
- AMBC 48.88
- ABUS 54.07
- Support Level
- AMBC $11.25
- ABUS $3.24
- Resistance Level
- AMBC $11.99
- ABUS $3.44
- Average True Range (ATR)
- AMBC 0.32
- ABUS 0.12
- MACD
- AMBC 0.02
- ABUS 0.01
- Stochastic Oscillator
- AMBC 45.95
- ABUS 55.56
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. The business operations of the company include Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. The Company has three reportable segments namely Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. Majority of revenues are earned from Legacy Financial Guarantee Insurance segment.
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.